CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases

Estimated time to complete activity: 1 hour 30 minutes

Compatible with all modern internet browsers and mobile devices

EDUCATIONAL OBJECTIVES

  • Review the development of CAR T-cells up to the present day

  • Understand the implementation of CAR T-cells in the treatment of autoimmune diseases

  • Assess the risks, reservations, opportunities, and future potential of CAR T in autoimmune diseases

TARGET AUDIENCE

This activity is designed for qualified rheumatologists of all levels of seniority, and other healthcare professionals involved or interested in CAR T-cell therapy for treating patients with inflammatory diseases.

PROGRAMME OVERVIEW

In this webinar, CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases, experts discuss the development of CAR T-cell therapy in oncology, including next-generation CARs. The application of CAR T to autoimmune diseases is then highlighted, alongside the potential risks and reservations associated with this therapeutic approach. This is followed by an interactive Q&A session between the audience and our panel of industry experts.

DISCLOSURE OF CONFLICTS OF INTEREST

CESAS Medical requires faculty, presenters, planners, managers, writers, and any other individuals who are in a position to influence the content of this activity to disclose any real and/or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly reviewed and resolved according to CESAS Medical policy.

Modules